LINC 2015 Programme

Find all topics and speakers listed below.

Main Arena 1

22 events
  • Tuesday, January 27th: - , Main Arena 1

    Symposium: Enhancing treatment in SFA & Pop lesions subsets with SUPERA

    Chairman:
    Dierk Scheinert
    Moderator:
    Ramon Varcoe, Steven Kum, Chris Metzger, Peter Goverde
    1. -

      Introduction by the chairman

    2. -

      SUPERB – 3 year follow up

        Lawrence Garcia
    3. -

      SUPERA data – long-term follow up/5 years

        Dierk Scheinert
    4. -

      Evolving strategies and economic considerations in treatment of femoropopliteal arterial disease

        Michael Jaff
    5. -

      A real world experience using SUPERA in long challenging lesions: patency results, deployment pitfalls and insights into mode of failure

        Ramon Varcoe
    6. -

      Optimal implantation deployment for optimal clinical outcome

        Chris Metzger
    7. -

      Live case transmission from Leipzig

    8. -

      The great debate: So many technologies – what is the optimal treatment for the SFA? (atherectomy, DCB, SNS, Covered, DES, SUPERA etc.)

  • Tuesday, January 27th: - , Main Arena 1

    Changing paradigms and future concepts in peripheral interventions

    Chairman:
    Dierk Scheinert, Gary Ansel
    Moderator:
    Karl-Ludwig Schulte, Steven Kum, Erich Minar, Andrew Holden, Michael Jaff, Iris Baumgartner
    1. -

      Drug-coated balloons: Finally proven as the first-line therapy for femoro-popliteal de-novo lesions?

    2. -

      In.Pact-SFA clinical trial: Update on 1-year data

        Gunnar Tepe
    3. -

      LEVANT II clinical trial: 2-year data

        Dierk Scheinert
    4. -

      My take-home messages from LEVANT II and In.Pact SFA – a critical review

        Michael Jaff
    5. -

      Panel discussion and vote

    6. -

      Live case transmission from Leizpig part I

    7. -

      Future prospects for DCB and alternative endovascular concepts

    8. -

      DCB + atherectomy: The ISAR STATH trial results

        Massimiliano Fusaro
    9. -

      DCB + atherectomy for complex lesions: DEFINETIVE AR – Final data

        Gunnar Tepe
    10. -

      Early look at the VISION Trial: OCT guided atherectomy using Avinger's Pantheris catheter

        Arne Schwindt
    11. -

      The role of vessel preparation – insights from the Heidelberg PANTHER registry

        Erwin Blessing
    12. -

      A future concept for drug delivery: The Mercator Bullfrog technology

        Dierk Scheinert
    13. -

      Live case transmission from Leipzig part II

    14. -

      Should all stents promote swirling flow?

        Thomas Zeller
    15. -

      The TOBA-trial 12 months results with the Tack-device for dissection sealing in the SFA

        Marc Bosiers
    16. -

      Biodegradable vascular scaffolds – how far have we come?

        Iris Baumgartner
  • Tuesday, January 27th: - , Main Arena 1

    Symposium: Drug-eluting technologies – the final 5 year conclusions. The guide to drug-elution and how to keep SFA treatment simple

    Chairman:
    Michael Dake
    Moderator:
    Konstantinos Katsanos, Fabrizio Fanelli, Andrew Holden
    1. -

      Introduction by the chairman

    2. -

      Zilver PTX – 5 year results

        Michael Dake
    3. -

      A treatment algorithm for drug eluting technologies

        Konstantinos Katsanos
    4. -

      Live case transmission from Leipzig

    5. -

      How I use drug-eluting devices in my practice

        Andrew Holden
    6. -

      Live case transmission from Dendermonde

    7. -

      Zilver PTX made easy

        Fabrizio Fanelli
    8. -

      Discussion and conclusion

  • Tuesday, January 27th: - , Main Arena 1

    Lunch

  • Tuesday, January 27th: - , Main Arena 1

    Symposium: DCB setting the stage for standard of care – an evidence-based review

    Chairman:
    Erich Minar
    Moderator:
    Peter Gaines, Gunnar Tepe, Gary Ansel, Hans Krankenberg, William Gray
    1. -

      IN.PACT in fem-pop TASC A-B and diabetics

        Gunnar Tepe
    2. -

      Live case transmission from Leipzig

    3. -

      IN.PACT global sub-analysis update: TASC C-D lesions

        Gary Ansel
    4. -

      DCB and ISR: Insights from FAIR study

        Hans Krankenberg
    5. -

      Are all DCB equal?

        William Gray
    6. -

      Live case transmission from Cotignola

    7. -

      IN.PACT role in SFA: Critical overview of modern endovascular therapies

        Frank Vermassen
  • Tuesday, January 27th: - , Main Arena 1

    Current concepts and advances for long femoropopliteal lesions and in-stent restenosis

    Chairman:
    Tony Das
    Moderator:
    Jörn Balzer, Francesco Liistro, Peter Gaines, Marc Bosiers, Sabine Steiner, Michael Werk, Roberto Gandini
    1. -

      What works best for long SFA disease? A review of the evidence

        Marc Bosiers
    2. -

      After 10.000+ DCB: How has this technology changed our clinical practice for complex SFA lesions?

        Andrej Schmidt
    3. -

      One-year follow-up of the DEBAS STUDY

        Patrice Mwipatayi
    4. -

      Is the combination of DCB and bare metal stents as effective as DES? The BIOLUX 4EVER trial

        Marc Bosiers
    5. -

      Live case transmission from Dendermonde

    6. -

      The endoluminal bypass – the best solution for long lesions and ISR?

        Peter Soukas
    7. -

      The Leipzig experience with DCB, conventional, and interwoven nitinol stents for complex SFA disease

        Sabine Steiner
    8. -

      Live case transmission from Leipzig

    9. -

      Excimer laser atherectomy for in-stent restenosis: Results of the EXCITE trial

        Eric Dippel
    10. -

      The Copa Cabana study: DEB vs. POBA in in-stent restenosis

        Gunnar Tepe
    11. -

      The cost economic value of DCB

        Konstantinos Katsanos
  • Tuesday, January 27th: - , Main Arena 1

    Scrub in with the experts: Solutions for severely calcified lesions, ISR and beyond

    live from Leipzig:
    Sven Bräunlich, Andrej Schmidt
    Chairman:
    Lawrence Garcia
    Moderator:
    Steve Ramee, Hermann Steinkamp, Andrew Holden, Ramon Varcoe, Miguel Montero-Baker, Sebastian Sixt
    1. -

      The Shockwave lithoplasty concept – finally the solution for calcified lesions?

        Andrew Holden
    2. -

      Our experience with biomimetic stent technology for severely calcified long lesions

        Donald Jacobs
    3. -

      The challenge of vessel calcification in different vascular beds: What are we dealing with?

        Jihad Mustapha
  • Wednesday, January 28th: - , Main Arena 1

    Symposium: Mechanical removal of occlusion material from arteries and veins – the new standard treatment?

    Chairman:
    Dierk Scheinert
    Moderator:
    Steven Kum, Michael Lichtenberg, Thomas Heller, Samuel Heller, Eberhard Wedell, Bruno Freitas
    1. -

      Introduction by the chairman

    2. -

      Rotarex mechanical debulking: The Leipzig experience in 1.200+ patients

        Dierk Scheinert
    3. -

      Live case transmission from Leipzig

    4. -

      Successful recanalisation of venous occlusions with Aspirex mechanical thrombectomy. The 50-cases-experience

        Michael Lichtenberg
    5. -

      Live case transmission from Leipzig

    6. -

      In-stent reocclusion: Why do we use mechanical debulking as first treatment step?

        Bruno Freitas
    7. -

      Discussion and conclusion

  • Wednesday, January 28th: - , Main Arena 1

    Critical limb ischemia treatment 2014: Lessons learned, current status and future perspectives

    Chairman:
    Dierk Scheinert, Peter Schneider
    Moderator:
    Iris Baumgartner, Renu Virmani, Andrew Holden, Yoshiaki Yokoi, Michael Jaff
    1. -

      The rationale for the “Endovascular First” concept and how to implement it

        Peter Schneider
    2. -

      Real world CLI practice: Update from the CRITISCH registry

        Theodosios Bisdas
    3. -

      The Angiosome concept: Pro and cons

    4. -

      The BEST-CLI Trial: Open vs. endovascular therapy for critical limb ischemia

        Michael Jaff
    5. -

      Revascularization of the wound-related artery is key

        Osamu Iida
    6. -

      Live case transmission from Leipzig part I

    7. -

      There is no proof for the angiosome concept

        Peter Huppert
    8. -

      Panel discussion and vote

    9. -

      Drug-coated balloons for BTK disease in critical limb ischemia – a failed concept?

    10. -

      One year after In.Pact Deep: Lessons learned from a failed trial

        Thomas Zeller
    11. -

      Safety of Paclitaxel balloon coatings: Insights from a pathologist

        Renu Virmani
    12. -

      Ongoing trials and future concepts for local drug delivery in BTK arteries

        Dierk Scheinert
    13. -

      Panel discussion and vote

    14. -

      Live case transmission from Leipzig part II

    15. -

      Destiny II: 12 months results with long segment DES treatment in BTK arteries

        Marc Bosiers
    16. -

      PES BTK 70: 12 months results with a paclitaxel-coated self-expandingstent in BTK arteries

        Marc Bosiers
    17. -

      Initial experience with absorbable drug-eluting vascular scaffolds in BTK arteries

        Ramon Varcoe
  • Wednesday, January 28th: - , Main Arena 1

    Symposium: Unique technologies for the treatment of peripheral artery disease

    Chairman:
    Michel Reijnen
    Moderator:
    Eric Verhoeven
    1. -

      Introduction by the chairman

    2. -

      Endovascular treatment with the new generation stent design of the GORE® TIGRIS® Vascular Stent

        Konstantinos Katsanos
    3. -

      Live case transmission from Dendermonde

    4. -

      Collateral damage in endovascular treatment of SFA occlusive disease: fact or fiction?

        Rombout Kruse
    5. -

      Live case transmission from Leipzig

    6. -

      Revising dysfunctional and thrombosed dialysis access: my experiences and clinical outcome

        Christian Hohl
    7. -

      Discussion and conclusion by the chairman

  • Wednesday, January 28th: - , Main Arena 1

    Lunch symposium: Endovascular procedures – how to choose the right device for complex procedures

    Chairman:
    Dierk Scheinert
    Moderator:
    Patrick Bagan, Konstantinos Donas, Michel Reijnen
    1. -

      Introduction by the chairman

    2. -

      Local drug delivery for acute occlusions in the peripheral arteries

        Patrick Bagan
    3. -

      Performance of renal covered stents in the endovascular treatment of pararenal pathologies

        Konstantinos Donas
    4. -

      Live case transmission from Leipzig

    5. -

      When not to use a bare metal stent – when not to use a covered stent for iliac stenotic lesions

        Michel Reijnen
    6. -

      Discussion and conclusion by the chairman

  • Wednesday, January 28th: - , Main Arena 1

    Symposium: Lutonix® DCB – Discussion on pre-clinical saftey studies, new insights from LEVANT2, Real World experience and the role of DCB in treatment of critical limb ischemia

    Chairman:
    Michael Jaff
    Moderator:
    Renu Virmani, Marcus Thieme, Marianne Brodmann, Jihad Mustapha
    1. -

      Not all DCBs are created equal: Side by side pre-clinical safety evaluation of leading DCBs

        Renu Virmani
    2. -

      Live case transmission from Leipzig

    3. -

      New insights from LEVANT2: Randomized 12 month data and post hoc analysis

        Dierk Scheinert
    4. -

      A first look and interim analysis of 12 month outcomes from the Real World Global SFA registry

        Marcus Thieme
    5. -

      Live case transmission from Leipzig

    6. -

      Role of DCBs in treating critical limb ischemia and the enrollment update on-going Lutonix® BTK clinical trial

        Marianne Brodmann
    7. -

      Discussion on physiology of CLI in utility of DCB in below-the-knee procedures

        Jihad Mustapha
    8. -

      German single center experience with Lutonix® DCB in BTK

        Sabine Steiner
  • Wednesday, January 28th: - , Main Arena 1

    VIVA @ LINC: Renal and visceral disease: pressing new dilemmas and pushing the field forward

    Chairman:
    Chris Metzger
    Moderator:
    Michael Jaff, Tony Das, Peter Schneider, Felix Mahfoud, Michael Moche, Jos van den Berg, Henrik Schröder
    1. -

      Introduction by the chairman

    2. -

      CORAL trial aftermath: What do we do now? Renal revascularisation in perspective

        Michael Jaff
    3. -

      Live case transmission from Teaneck

    4. -

      How to assess the hemodynamic importance of a renal artery stenosis

        Felix Mahfoud
    5. -

      Endovascular treatment of mesenteric angina: Tips, tricks, and techniques

        Chris Metzger
    6. -

      Live case transmission from Teaneck

    7. -

      Visceral artery aneurysms. The silent killer comes into focus now that we can find them and fix them

        Michael Dake
    8. -

      Discussion and conclusion

  • Wednesday, January 28th: - , Main Arena 1

    The last frontiers: Interventional treatment of the popliteal artery

    Chairman:
    Jörn Balzer, Tony Das
    Moderator:
    Patrick Peeters, Peter Gaines, Reza Ghotbi, Lawrence Garcia, Eberhard Wedell
    1. -

      Balloon, DCB or stent? What is standard of interventional treatment in the popliteal artery?

        Martin Werner
    2. -

      The utility of the retrograde proximal anterior tibial access for challenging femoropopliteal occlusions

        Michael Piorkowski
    3. -

      Live case transmission from Leipzig

    4. -

      1 year results of the Gore TIGRIS® vascular stent in femoropopliteal lesions

        Martin Werner
    5. -

      Treatment of popliteal aneurysms: Endo or open?

        Jürgen Verbist
    6. -

      Live case transmission from Münster

  • Thursday, January 29th: - , Main Arena 1

    Innovative approaches and hot topics in endovascular interventions

    Chairman:
    Lawrence Garcia
    Moderator:
    Koen Deloose, Josef Tacke, Michael Lichtenberg, William Gray, Sigrid Nikol, Lieven Maene, Erich Minar
    1. -

      Does stent design influence the results of SFA stenting?

        Koen Deloose
    2. -

      New approaches for drug-eluting stents: The NitiDES programme

        Dierk Scheinert
    3. -

      Recorded case via satellite from Münster

    4. -

      Results from the Freeway Stent study

        Josef Tacke
    5. -

      ILLUMENATE Direct: 12 months results with direct DCB use in femoropopliteal arteries

        Stephan Duda
    6. -

      Next generation DCB coating–the EffPac-trial

        Sebastian Sixt
    7. -

      Live case transmission from Bad Krozingen

    8. -

      RELINE-trial: 24 months results with the Viabahn vs. PTA for in-stent restenosis

        Koen Deloose
    9. -

      The role of DCB for SFA-ISR

        Yann Gouëffic
    10. -

      First experience with DCB in AV-fistulas

        Stephan Duda
    11. -

      The utility of carbon-dioxide angiography in peripheral interventions

        Ulf Teichgräber
    12. -

      Using ARROW GPSCath to protect wire placement, reduce fluoroscopy while minimizing contrast

        Michael Lichtenberg
    13. -

      Discussion and conclusion

  • Thursday, January 29th: - , Main Arena 1

    Symposium: Individually excellent, together outstanding? Is DEB plus Stent the future for SFA therapy?

    Chairman:
    Marc van Sambeek
    Moderator:
    Francesco Liistro, Michael Lichtenberg, Paul Myers, Koen Deloose, Peter Soukas
    1. -

      Introduction by the chairman

    2. -

      Proven: Pulsar stent technology

        Michael Lichtenberg
    3. -

      Live case transmission from Bad Krozingen

    4. -

      Proven: Passeo-18 Lux drug releasing balloon technology

        Paul Myers
    5. -

      Live case transmission from Leipzig

    6. -

      Proven? Combining DEB and stent

        Koen Deloose
    7. -

      Discussion and conclusion

  • Thursday, January 29th: - , Main Arena 1

    Symposium: Clearing a path for the effective treatment of complex arterial and venous disease

    Chairman:
    Dierk Scheinert, William Gray
    Moderator:
    Mario Galli, Gerard O'Sullivan
    1. -

      Introduction and learning objectives

    2. -

      An open toolbox and open questions – where are we in Europe with drug elution, atherectomy and thrombectomy in 2015

        Dierk Scheinert
    3. -

      The utility of atherectomy and the Jetstream™ atherectomy system

        William Gray
    4. -

      Live case transmission from Bad Krozingen

    5. -

      Reducing thrombotic burden in arterial interventions

        Mario Galli
    6. -

      The importance of thrombectomy and stenting in venous intervention – case reviews and Angiojet™ AVX Thrombectomy™ system

        Gerard O'Sullivan
    7. -

      Closing and take home messages

  • Thursday, January 29th: - , Main Arena 1

    Lunch

  • Thursday, January 29th: - , Main Arena 1

    Latest insights from cardiovascular clinical trials

    Chairman:
    William Gray
    Moderator:
    Felix Mahfoud, Dietrich Pfeiffer, Dariusz Dudek, Joachim Schofer, Christian Etz
    1. -

      After SIMPLICITY III: Is there a future for catheter-based therapy of arterial hypertension?

        Michael Böhm
    2. -

      Review of results of the European, randomized trial of AV anastomosis with the ROX coupler for resistant hypertension

        Paul Sobotka
    3. -

      Live case transmission from Leipzig Heartcenter

    4. -

      The role of TAVI in high-risk and normal-risk patients

        Joachim Schofer
    5. -

      Echocardiographic criteria for favourable TAVI outcome – can we predict the risk?

        Andreas Hagendorff
    6. -

      Cerebral protection during TAVI – the CLEAN-TAVI trial

        Stephan Haußig
    7. -

      Live case transmission from Leipzig

    8. -

      Stroke prevention in patients with atrial fibrillation: When and how to use left atrium appendix closure?

        Dietrich Pfeiffer
    9. -

      Current status of ablation therapy for atrial fibrillation

        Philipp Sommer
    10. -

      Discussion and conclusion

  • Thursday, January 29th: - , Main Arena 1

    Symposium: Sustained embolic protection – shifting paradigms in carotid artery stenting?

    Chairman:
    Piotr Odrowaz-Pieniazek
    Moderator:
    Marco Roffi, Giovanni Torsello, Antonio Micari
    1. -

      The concept of Roadsaver carotid micromesh stent

        Stefan Müller-Hülsbeck
    2. -

      Live case transmission from Münster

    3. -

      Future perspectives of micromesh stents

        Antonio Micari
    4. -

      Clinical evidence for Roadsaver carotid stent – the CLEAR-ROAD Trial

        Koen Deloose
    5. -

      What can we learn from our real-world CAS practice?

        Maria Antonella Ruffino
    6. -

      Roadsaver – the optimal solution for all carotid lesions?

        Giovanni Torsello
    7. -

      Discussion and conclusion

  • Thursday, January 29th: - , Main Arena 1

    The last frontiers: Endovascular treatment of common femoral artery lesions and pioneering solutions for TASC D+ lesions

    Chairman:
    Patrick Peeters, Sebastian Debus
    Moderator:
    Sebastian Sixt, Chris Metzger, Paul Myers, Jihad Mustapha, Keisuke Hirano
    1. -

      Available techniques and outcome of endovascular procedures in the common femoral artery

        Thomas Zeller, Via satellite from Bad Krozingen
    2. -

      Live case transmission from Bad Krozingen

    3. -

      Surgical techniques for optimal reconstruction of the common femoral and external iliac segment

        Sebastian Debus
    4. -

      The value of hybrid procedures through the common femoral artery open access

        Daniela Branzan
    5. -

      Live case transmission from Leipzig

  • Friday, January 30th: - , Main Arena 1

    Critical issues in aortic endografting

    Chairman:
    Vicente Riambau
    Moderator:
    Reza Ghotbi, Piergiorgio Cao, Frank Veith, Armando Lobato, Giovanni Torsello
    1. -

      Live case transmission from Münster

    2. -

      Renaissance of the tube in EVAR – infrarenal double tubing with endo anchor augmentation

        Johannes Gahlen
    3. -

      Innovative device design and delivery sytems – exploring current and future device capabilities

        Dittmar Böckler
    4. -

      Total endovascular aortic arch replacement with the sandwich technique

        Armando Lobato
    5. -

      Long-term results of chimneys and sandwich grafts in the aortic arch

        Ralf Kolvenbach
    6. -

      Concurrent comparison between hypogastric artery interruption, bell- bottom and sandwich techniques: Long-term follow-up

        Armando Lobato
    7. -

      EVAR is better than open repair for ruptured AAAs despite recent level one evidence: IMPROVE, AJAX & ECAR are misleading

        Frank Veith
    8. -

      Improving care of patients with ruptured AAA: lessons from the USA and the UK

        Matt Thompson
    9. -

      One hundred percent of ruptured abdominal aortic aneurysms can be treated endovascularly if adjunctive techniques are used

        Thomas Larzon
    10. -

      Live case transmission from Leipzig

    11. -

      How to implement a successful programme for EVAR of ruptured aneurysms

        Zoran Rancic
    12. -

      Management of aortic disease in the state of infection or inflammation

        Martin Malina
    13. -

      Experience with re-do procedures in patients with infected endovascular or surgical aortic grafts

        Olaf Richter
    14. -

      Re-do procedures after stent-graft migration or graft component disconnection

        Andreas Gussmann
    15. -

      When are stent-grafts a reasonable option for aneurysm patients with connective tissue disease?

        Vicente Riambau
    16. -

      Live case transmission from Münster

    17. -

      Discussion and conclusion